ASLN | ASLAN Pharmaceuticals
Quick infos Trade prices Volume: Market Cap: 35.58M Prev closed: Open: 3.14 High: 3.14 Low: 2.97 52 week low: 1.36 52 week high: 6.75 Dividends: No Dividends Next ER: March 24, 2023 Before Market Opens
Company Profile ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for global markets.
Earnings History Date EPS / Forecast Revenue / Forecast May 1, 2023 March 24, 2023 -0.66 / -0.18- / -November 3, 2022 - / -0.19- / -August 12, 2022 -0.04 / -0.2- / -April 27, 2022 -0.19 / -0.18- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 12, 2022 0.880 0.711 0.940
0.711
912.15K 27.54% Aug 11, 2022 0.690 0.611 0.720
0.611
498.06K 15% Aug 10, 2022 0.600 0.570 0.600
0.540
215.25K 9.11% Aug 9, 2022 0.550 0.580 0.580
0.535
104.39K 2.79% Aug 8, 2022 0.535 0.540 0.583
0.520
46.32K 0.94% Aug 5, 2022 0.530 0.520 0.530
0.515
75.28K 3.90% Aug 4, 2022 0.510 0.510 0.520
0.495
135.58K 0.02% Aug 3, 2022 0.510 0.480 0.520
0.480
61.45K 7.75% Aug 2, 2022 0.473 0.460 0.496
0.460
57.32K 4.44% Aug 1, 2022 0.453 0.475 0.520
0.451
114.44K -2.12% view more
NASDAQ - Nasdaq Stock Market
News
ASLAN Pharmaceuticals GAAP EPS of -$0.02 seekingalpha.com Oct 28, 2022 7:29 pm ASLAN Pharma to start trial of eczema drug in patients with a previous treatment seekingalpha.com Sep 14, 2022 9:55 pm Catalyst watch: Amgen data, Starbucks & Roblox events and Twitter vote on Elon Musk deal seekingalpha.com Sep 10, 2022 3:00 am
Horizon (HZNP) and Halozyme Ink Deal for ENHANZE Technology finance.yahoo.com Sep 14, 2021 3:08 pm
Alkermes (ALKS) Receives FDA CRL in Relation to ALKS 3831 finance.yahoo.com Sep 14, 2021 11:13 am
vTv Therapeutics (VTVT) Gets Breakthrough Tag for Diabetes Drug finance.yahoo.com Sep 14, 2021 9:03 am Will Aslan Pharmaceuticals Ltd (ASLN) Stay at the Top of the Healthcare Sector? investorsobserver.com Sep 11, 2021 4:27 pm Where Does Aslan Pharmaceuticals Ltd (ASLN) Stock Fall in the Biotechnology Field After It Has Gained 12.55% This Week? investorsobserver.com Sep 7, 2021 4:27 pm Is Aslan Pharmaceuticals Ltd (ASLN) a Winner in the Biotechnology Industry? investorsobserver.com Jul 20, 2021 ASLAN Pharmaceuticals GAAP EPS of -$0.02 beats by $0.18 seekingalpha.com Aug 12, 2022 8:16 pm CRISPR, Xencor stock falls as Piper Sandler slashes price target in biotech space seekingalpha.com May 24, 2022 12:58 am ASLAN Pharmaceuticals GAAP EPADS of -$0.19 misses by $0.01 seekingalpha.com Apr 27, 2022 7:51 pm ASLAN Pharmaceuticals GAAP EPS of -$0.03 seekingalpha.com Mar 25, 2022 7:24 pm Aslan Pharmaceuticals appoints dermatology veteran Dr Alex Kaoukhov as CMO seekingalpha.com Mar 15, 2022 7:32 pm Aslan Pharmaceuticals begins phase2b study of ASLAN004 for eczema seekingalpha.com Jan 21, 2022 5:28 am ASLAN Pharmaceuticals EPS beats by $0.08 seekingalpha.com Oct 26, 2021 7:23 pm ASLAN Pharmaceuticals inks collaboration for mid-stage atopic dermatitis research program seekingalpha.com Oct 22, 2021 7:14 pm Aslan Pharma stock tanks 26% despite 'positive' ASLAN004 data in atopic dermatitis seekingalpha.com Sep 27, 2021 7:35 pm
ORIC Pharmaceuticals (ORIC) in Focus: Stock Moves 6.7% Higher finance.yahoo.com Sep 14, 2021 8:30 am
Momenta (MNTA) Provides Pipeline Updates, Stock Rallies finance.yahoo.com Sep 14, 2021 8:22 am This company doesn't provide a dividend.
Talk about ASLAN Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet